0001594062-19-000037.txt : 20190521
0001594062-19-000037.hdr.sgml : 20190521
20190521155339
ACCESSION NUMBER: 0001594062-19-000037
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20190521
DATE AS OF CHANGE: 20190521
EFFECTIVENESS DATE: 20190521
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Qrons Inc.
CENTRAL INDEX KEY: 0001689084
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 813623646
STATE OF INCORPORATION: WY
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-340093
FILM NUMBER: 19842304
BUSINESS ADDRESS:
STREET 1: 50 BATTERY PLACE, #7T
CITY: NEW YORK
STATE: NY
ZIP: 10280
BUSINESS PHONE: 212-945-2080
MAIL ADDRESS:
STREET 1: 50 BATTERY PLACE, #7T
CITY: NEW YORK
STATE: NY
ZIP: 10280
FORMER COMPANY:
FORMER CONFORMED NAME: BIOLABMART INC.
DATE OF NAME CHANGE: 20161102
D
1
primary_doc.xml
X0708
D
LIVE
0001689084
Qrons Inc.
50 BATTERY PLACE, #7T
NEW YORK
NY
NEW YORK
10280
212-945-2080
WYOMING
BIOLABMART INC.
Corporation
true
2016
Jonah
Meer
50 Battery Place, # 7T
New York
NY
NEW YORK
10280
Executive Officer
Director
Ido
Merfeld
153 Hagilboa Street
Nirit
L3
ISRAEL
44805
Executive Officer
Director
Biotechnology
Decline to Disclose
- 06b
false
true
false
true
true
false
10000
Network 1 Financial Services Inc.
13577
None
None
2 Bridge Avenue. Suite 241
Red Bank
NJ
NEW JERSEY
07701
CT
CONNECTICUT
FL
FLORIDA
NJ
NEW JERSEY
NY
NEW YORK
false
1000000
0
1000000
false
0
100000
true
0
Sales commissions is 10% of the gross proceeds sold. Placement Agent will also receive a four-year warrant to purchase 10% of the shares sold at an exercise price of $2.50 per share and a 3% cash fee of the proceeds from the exercise of the warrants sold.
0
false
Qrons Inc.
/s/Jonah Meer
Jonah Meer
Chief Executive Officer
2019-05-21